NCT02037971

Brief Summary

The purpose of this study is to determine the effectiveness of exercise training on improving sleep in patients with systemic lupus erythematosus.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 24, 2013

Completed
10 months until next milestone

First Posted

Study publicly available on registry

January 16, 2014

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

January 16, 2014

Status Verified

May 1, 2013

Enrollment Period

1 year

First QC Date

March 24, 2013

Last Update Submit

January 14, 2014

Conditions

Keywords

Systemic Lupus ErythematosusLupusSleep disordersSleep disturbedPhysical exerciseAerobic exercise

Outcome Measures

Primary Outcomes (2)

  • Sleep Efficiency

    Sleep efficiency will be evaluate with actigraph. The subject will use it for 15 days before the period of exercise, 15 days at the start of the period of exercise, and then 15 last days in the period of exercise. Complementing the information collected by the device, the patient will complete a sleep diary, with schedules of activities such as: time they go to bed, time they fall asleep, time they get up, times they remove the device (which is not waterproof), times they replace the device, and times they wake up from naps.

    16 weeks

  • Sleep quality

    The Pittsburgh Sleep Quality Index (PSQI) is a questionnaire that includes 21 items that assess the quality of sleep during a one-month period. The subject will be asked it, before, during and after the period of exercise. The questionnaire is divided into seven components: subjective sleep quality, sleep latency, sleep duration, sleep effectiveness, sleep disorder, use of sleep medication, and daytime dysfunction. On the PSQI a score ≥ 5 indicates poor quality of sleep, and ≤ 4 indicates good quality of sleep.

    16 weeks

Secondary Outcomes (6)

  • Pain assessment

    16 weeks

  • Disease activity assessment

    16 weeks

  • Quality of life assessment

    16 weeks

  • Restless Legs Syndrome gravity assessment

    16 weeks

  • Fatigue assessment

    16 weeks

  • +1 more secondary outcomes

Study Arms (2)

Aerobic Exercise

EXPERIMENTAL

Subjects will follow one defined exercise process, according their cardiopulmonary exercise test, during 16 weeks, two times per a week.

Procedure: Aerobic Exercise

Control Group

EXPERIMENTAL

A non-exercise group will receive regular educational information relating to their condition.

Other: Control Group

Interventions

From 1st week up to and including 4th week, subjects will do: 5 minutes warm-up, then 15-30 minutes low to moderate (55-65% VO2) exercise, then 15 minutes stretching. From 5th week up to and including 16th week, subjects will do: 5 minutes warm-up, then intermittent training for between 30-40 minutes, then 10 minutes stretching.

Also known as: Physical activity, Physical training
Aerobic Exercise

The control group will have monthly meetings to learn about: good sleep habits, Systemic Lupus Erythematosus (their disease) and general good health.

Control Group

Eligibility Criteria

Age18 Years - 69 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Systemic Lupus Erythematosus (SLE) according American College of Rheumatology (ACR) Criteria revised in 1997;
  • Pittsburgh sleep quality index (PSQI) ≥ 5;
  • Free and Clarified Consent Term signature.

You may not qualify if:

  • Patients who have other rheumatologic diseases (rheumatoid arthritis, sjogren syndrome, fibromyalgia, ankylosis spondylitis), excerpt mild osteoarthritis;
  • Systemic Lupus Erythematosus Disease Assessment Index (SLEDAI) \> 8;
  • Untreated diseases: Hypertension, diabetes mellitus (DM), dyslipidemia, thyroid dysfunction, cardiorespiratory diseases, malignancies;
  • Patients who do not accept the study rules as time and/or follow-up exercise program time proposed;
  • Suspected or pregnancy confirmation;
  • \* Patients who are taking sleeping medication;
  • Patients who won´t sign the Free and Clarified Consent Term informed;
  • Patients engaged in physical activity (defined as previously sedentary individuals, or that which do not perform any type of regular physical activity at least six months);

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Psychobiology and Exercise Studies Centre

São Paulo, São Paulo, 04020-050, Brazil

RECRUITING

MeSH Terms

Conditions

Lupus Erythematosus, SystemicSleep Wake DisordersParasomniasMotor Activity

Interventions

ExercisePhysical Conditioning, HumanControl Groups

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Lilian KC Reis

    Federal University of São Paulo UNIFESP

    STUDY CHAIR
  • Virginia FM Trevisani

    Federal University of São Paulo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 24, 2013

First Posted

January 16, 2014

Study Start

February 1, 2013

Primary Completion

February 1, 2014

Study Completion

March 1, 2015

Last Updated

January 16, 2014

Record last verified: 2013-05

Locations